CR Pharmaceutical Subsidiary CR Sanjiu Posts Higher Q1 Revenue but Weaker Cash Flow

China Resources Sanjiu (000999.SZ) released its first-quarter performance, with a net profit attributable to shareholders of 1.076 billion yuan, representing a year-on-year decrease of 15.29%.

China Resources Pharmaceutical (03320.HK) Subsidiary China Resources Sanjiu (000999.SZ) 1Q Net Profit RMB1.209 billion, Down 9.2% YoY